Literature DB >> 19229953

Nocturia: an Austrian study on the multifactorial etiology of this symptom.

H Christoph Klingler1, Helmut Heidler, Helmut Madersbacher, Guenter Primus.   

Abstract

AIMS: To identify the different factors contributing to nocturia in a clinical setting. PATIENTS AND METHODS: Three hundred twenty-four patients (133 women, 191 men; mean age 63 years) were entered into this multi-institutional study. When presenting with nocturia we obtained detailed medical history and performed urine analysis, post-void residual volume and renal ultrasonography. Bothersome score and quality of life were evaluated using visual analogue scale and Kings' Health Questionnaire (KHQ), respectively. Patients were asked to complete a 48-hr voiding diary (VD). Nocturia and its associated problems were evaluated using KHQ and VD in conjunction with concurrent health variables.
RESULTS: Mean nocturia was 2.8 in men versus in 3.1 women. Fifty percent of patients were aged >65 years, 60% had daytime lower urinary tract symptoms (LUTS) as well as nocturia, 33% had cardiac pathologies and 7% had peripheral edema. Principal causes for nocturia were global polyuria in 17%, nocturnal polyuria (NP) in 33% and reduced functional capacity <250 ml in 16.2%; 21.2% had mixed forms of NP and reduced bladder capacity and 12.6% suffered from other causes. Mean bothersome score was higher in women (P < 0.001) and in patients with NP (P = 0.012). Quality of life was significantly lower in women (P = 0.001), in patients aged >65 years (P = 0.029) and in those with reduced functional capacity (P < 0.001). Mean voided 24-hr urine was higher in women (P = 0.033) and in patients aged <65 years (P = 0.019).
CONCLUSIONS: Nocturia had a high impact on bothersome score, strong associations with poor health and other LUTS. NP was the predominant cause of nocturia. Neurourol. Urodynam. 28:427-431, 2009. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19229953     DOI: 10.1002/nau.20665

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  8 in total

1.  Influence of type of nocturia and lower urinary tract symptoms on therapeutic outcome in women treated with desmopressin.

Authors:  Jae Young Jeong; Su Jin Kim; Hyuk Jin Cho; Sung Hoo Hong; Ji Youl Lee; Tae Kon Hwang; Sae Woong Kim
Journal:  Korean J Urol       Date:  2013-02-18

2.  The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study.

Authors:  Byung Hoon Kim; Ki Ho Kim; Young Hwii Ko; Phil Hyun Song; Tae-Hwan Kim; Bum Soo Kim
Journal:  Prostate Int       Date:  2016-01-14

3.  Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia.

Authors:  Hiroshi Yagi; Kojiro Nishio; Ryo Sato; Gaku Arai; Shigehiro Soh; Hiroshi Okada
Journal:  J Tradit Complement Med       Date:  2015-01-30

4.  Development of a multivariate prediction model for nocturia, based on urinary tract etiologies.

Authors:  Tine Kold Olesen; Marie-Astrid Denys; An-Sophie Goessaert; Elke Bruneel; Veerle Decalf; Thibault Helleputte; Jerome Paul; Pierre Gramme; Karel Everaert
Journal:  Int J Clin Pract       Date:  2019-02-28       Impact factor: 2.503

5.  Jingui Shenqi pill for nocturia due to nocturnal polyuria: A protocol for systematic review and meta-analysis.

Authors:  Zhipeng Fan; Zhaodi Wang; Jiashuai Deng; Yong Jiang
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

6.  Association of multimorbidity with higher levels of urinary incontinence: a cross-sectional study of 23 089 individuals aged ≥15 years residing in Spain.

Authors:  Louis Jacob; Guillermo Felipe López-Sánchez; Hans Oh; Jae Il Shin; Igor Grabovac; Pinar Soysal; Petre Cristian Ilie; Nicola Veronese; Ai Koyanagi; Lee Smith
Journal:  Br J Gen Pract       Date:  2020-12-28       Impact factor: 5.386

7.  Dietary salt with nitric oxide deficiency induces nocturnal polyuria in mice via hyperactivation of intrarenal angiotensin II-SPAK-NCC pathway.

Authors:  Y Sekii; H Kiuchi; K Takezawa; T Imanaka; S Kuribayashi; K Okada; Y Inagaki; N Ueda; S Fukuhara; R Imamura; H Negoro; N Nonomura
Journal:  Commun Biol       Date:  2022-02-28

8.  Is It Worth Treating Non-Bothering Nocturia? Results of a Multicenter Prospective Observational Study.

Authors:  Kwangsung Park; Hyoung Keun Park; Sae Woong Kim; Dae Yul Yang; Jong Kwan Park; Hyun Jun Park; Ki Hak Moon; Du Geon Moon; Kweon Sik Min; Hwancheol Son; Sung Won Lee; Jae Seog Hyun; Woo Suk Choi; Sang Kuk Yang
Journal:  World J Mens Health       Date:  2018-05-17       Impact factor: 5.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.